Simplex Trading
VKTX icon

Simplex Trading’s Viking Therapeutics VKTX Stock Holding History

Simplex Trading’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-33,354
Closed -$1.18M – 10197
2025
Q3 		$876K Sell
33,354
-70,466
-68% -$2.1M ﹤0.01% 3192
2025
Q2 		$2.75M Sell
103,820
-18,935
-15% -$498K ﹤0.01% 1831
2025
Q1 		$2.96M Buy
122,755
+90,614
+282% +$2.86M ﹤0.01% 1672
2024
Q4 		$1.29M Sell
32,141
-28,840
-47% -$1.64M ﹤0.01% 2596
2024
Q3 		$3.86M Sell
60,981
-20,326
-25% -$1.19M ﹤0.01% 1697
2024
Q2 		$4.31M Buy
81,307
+23,308
+40% +$1.53M ﹤0.01% 1543
2024
Q1 		$4.75M Buy
+57,999
New +$2.58M ﹤0.01% 1639
2023
Q2 		– Sell
-289,240
Closed -$6.06M – 10035
2023
Q1 		$4.82M Sell
289,240
-108,853
-27% -$1.12M ﹤0.01% 1326
2022
Q4 		$3.74M Buy
398,093
+372,508
+1,456% +$1.66M ﹤0.01% 1406
2022
Q3 		$69K Buy
+25,585
New +$83.8K ﹤0.01% 6013
2022
Q2 		– Sell
-16,133
Closed -$39.9K – 11193
2022
Q1 		$48K Sell
16,133
-14,267
-47% -$51.2K ﹤0.01% 7198
2021
Q4 		$139K Buy
+30,400
New +$170K ﹤0.01% 5721
2020
Q2 		– Sell
-4,799
Closed -$31.9K – 8434
2020
Q1 		$22K Sell
4,799
-3,169
-40% -$19.5K ﹤0.01% 5887
2019
Q4 		$63K Sell
7,968
-59,443
-88% -$433K ﹤0.01% 4984
2019
Q3 		$463K Buy
67,411
+55,818
+481% +$415K ﹤0.01% 2700
2019
Q2 		$96K Buy
+11,593
New +$99.1K ﹤0.01% 4234
2019
Q1 		– Sell
-9,534
Closed -$79.8K – 7926
2018
Q4 		$72K Sell
9,534
-52,824
-85% -$632K ﹤0.01% 4179
2018
Q3 		$1.09M Buy
62,358
+47,404
+317% +$564K ﹤0.01% 1801
2018
Q2 		$141K Buy
14,954
+7,157
+92% +$47.6K ﹤0.01% 3888
2018
Q1 		$34K Buy
+7,797
New +$43.1K ﹤0.01% 2823

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Simplex Trading's VKTX Position: Q4 2025 in Review

Simplex Trading sold out of Viking Therapeutics (VKTX) in Q4 2025, closing a stake of 33,354 shares — an estimated $1.18M sold.

Simplex Trading first reported a position in VKTX in Q1 2018 and held it in 20 quarters. The position peaked at $4.82M in Q1 2023. 426 funds tracked by Wall St. Rank hold VKTX as of Q4 2025.

  • Simplex Trading reported no remaining Viking Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Simplex Trading sold 33,354 Viking Therapeutics shares in Q4 2025, an estimated $1.18M.
  • Simplex Trading first reported a position in Viking Therapeutics in Q1 2018 and held it in 20 quarters.
  • Simplex Trading's Viking Therapeutics position peaked at $4.82M in Q1 2023.
  • 426 funds tracked by Wall St. Rank held Viking Therapeutics as of Q4 2025.

Based on Simplex Trading's 13F filing for Q4 2025, filed 11 Feb 2026.